{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:57:10Z","timestamp":1787867830632,"version":"build-2784847793"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800515"],"award-info":[{"award-number":["81800515"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970708"],"award-info":[{"award-number":["81970708"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Nova Program of Science and Technology","award":["Z191100001119026"],"award-info":[{"award-number":["Z191100001119026"]}]},{"name":"Beijing Nova Cross program","award":["Z211100002121169"],"award-info":[{"award-number":["Z211100002121169"]}]},{"name":"Clinical Medicine Plus X - Young Scholars Project, Peking University, the Fundamental Research Funds for the Central Universities","award":["PKU2022LCXQ004"],"award-info":[{"award-number":["PKU2022LCXQ004"]}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z201100005520013"],"award-info":[{"award-number":["Z201100005520013"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z201100005520012"],"award-info":[{"award-number":["Z201100005520012"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Phosphoglycerate mutase 5 (PGAM5), a phosphatase involved in mitochondrial homeostasis, is reported to be closely related to the metabolic stress induced by high-fat diet (HFD) or cold. In this study, we aimed to investigate the effects of PGAM5 on hepatic steatosis, inflammation and fibrosis in nonalcoholic steatohepatitis (NASH).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and results<\/jats:title>\n                <jats:p>We generated PGAM5 global knockout (GKO) mice and their wildtype (WT) littermates using CRISPR\/CAS9. The mice were fed with a high fat high fructose (HFHF) diet for 12\u00a0weeks or a methionine choline-deficient (MCD) diet (methionine choline supplemented (MCS) as control) for 6\u00a0weeks. Hepatic PGAM5 expression was up-regulated in humans with NASH and WT mice fed with HFHF and MCS, and reduced in WT mice fed with MCD diet. In HFHF-fed mice, GKO had reduced body weight, hepatic triglyceride (TG) content and serum transaminase along with decreased hepatic pro-inflammatory and pro-fibrotic responses compared with their WT control. GKO had increased expression of antioxidative gene glutathione peroxidase-6 (GPX6) and activation of mammalian target of rapamycin (mTOR). In mice fed with MCS diet, GKO significantly increased serum TNF-\u03b1 and IL-6 and decreased hepatic GPX6 mRNA expression. There was no difference in hepatic steatosis, inflammation or fibrosis between GKO and WT mice fed with MCD\u00a0diet. We investigated the role of PGAM5 deficiency in a variety of cell types. In differentiated THP-1 cells, PGAM5 silencing significantly increased pro-inflammatory cytokine secretion and decreased antioxidative proteins, including nuclear factor erythroid 2- related factors (NRF2), heme oxygenase-1 (HO-1) and GPX6 without affecting mTOR activity. In HepG2 cells with steatosis, PGAM5 knockdown reduced insulin sensitivity, increased mTOR phosphorylation and reduced the expression of NRF2, catalase (CAT), HO-1 and GPX6. Conversely, PGAM5 knockdown reduced TG accumulation, increased insulin sensitivity, and increased antioxidative genes in 3T3-L1 cells, despite the up-regulation in mTOR phosphorylation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PGAM5-KO relieved hepatic steatosis and inflammation in HFHF model, promoted inflammation in MCS-fed mice and had no effects on the MCD-fed model. The distinct effects may be owing to the different effects of PGAM5-KO on anti-oxidative pathways in energy-dependent, possible involves mTOR, and\/or cell type-dependent manner. Our findings suggest that PGAM5 can be a potential therapeutic target for NASH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13578-023-01095-3","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T06:02:49Z","timestamp":1692597769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Differential effects of PGAM5 knockout on high fat high fructose diet and methionine choline-deficient diet induced non-alcoholic steatohepatitis (NASH) in mice"],"prefix":"10.1186","volume":"13","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2349-3042","authenticated-orcid":false,"given":"Xiantong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"1095_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.12.002","author":"MH Le","year":"2021","unstructured":"Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, Ye Q, et al. 2019 global NAFLD prevalence: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021. https:\/\/doi.org\/10.1016\/j.cgh.2021.12.002.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1095_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328\u201357.","journal-title":"Hepatology"},{"key":"1095_CR3","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65:1038\u201348.","journal-title":"Metabolism"},{"key":"1095_CR4","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","volume":"62","author":"C Trautwein","year":"2015","unstructured":"Trautwein C, Friedman SL, Schuppan D, Pinzani M. Hepatic fibrosis: concept to treatment. J Hepatol. 2015;62:S15-24.","journal-title":"J Hepatol"},{"key":"1095_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2022.01.038","volume":"343","author":"JE Zhou","year":"2022","unstructured":"Zhou JE, Sun L, Liu L, Jia Y, Han Y, Shao J, Wang J, et al. Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis. J Control Release. 2022;343:175\u201386.","journal-title":"J Control Release"},{"key":"1095_CR6","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52:1836\u201346.","journal-title":"Hepatology"},{"key":"1095_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2020.151144","volume":"100","author":"M Cheng","year":"2021","unstructured":"Cheng M, Lin N, Dong D, Ma J, Su J, Sun L. PGAM5: A crucial role in mitochondrial dynamics and programmed cell death. Eur J Cell Biol. 2021;100: 151144.","journal-title":"Eur J Cell Biol"},{"key":"1095_CR8","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1074\/jbc.RA119.011508","volume":"295","author":"S Sugawara","year":"2020","unstructured":"Sugawara S, Kanamaru Y, Sekine S, Maekawa L, Takahashi A, Yamamoto T, Watanabe K, et al. The mitochondrial protein PGAM5 suppresses energy consumption in brown adipocytes by repressing expression of uncoupling protein 1. J Biol Chem. 2020;295:5588\u2013601.","journal-title":"J Biol Chem"},{"key":"1095_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ebiom.2016.01.031","volume":"5","author":"S Sekine","year":"2016","unstructured":"Sekine S, Yao A, Hattori K, Sugawara S, Naguro I, Koike M, Uchiyama Y, et al. The ablation of mitochondrial protein phosphatase Pgam5 confers resistance against metabolic stress. EBioMedicine. 2016;5:82\u201392.","journal-title":"EBioMedicine"},{"key":"1095_CR10","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/gutjnl-2015-311247","volume":"66","author":"GW He","year":"2017","unstructured":"He GW, Gunther C, Kremer AE, Thonn V, Amann K, Poremba C, Neurath MF, et al. PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury. Gut. 2017;66:716\u201323.","journal-title":"Gut"},{"key":"1095_CR11","doi-asserted-by":"publisher","first-page":"8371","DOI":"10.1038\/ncomms9371","volume":"6","author":"YJ Kang","year":"2015","unstructured":"Kang YJ, Bang BR, Han KH, Hong L, Shim EJ, Ma J, Lerner RA, et al. Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling. Nat Commun. 2015;6:8371.","journal-title":"Nat Commun"},{"key":"1095_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4049\/jimmunol.1501662","volume":"196","author":"K Moriwaki","year":"2016","unstructured":"Moriwaki K, Farias Luz N, Balaji S, De Rosa MJ, O\u2019Donnell CL, Gough PJ, Bertin J, et al. The mitochondrial phosphatase PGAM5 is dispensable for necroptosis but promotes inflammasome activation in macrophages. J Immunol. 2016;196:407\u201315.","journal-title":"J Immunol"},{"key":"1095_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbrc.2018.02.024","volume":"497","author":"Y Wang","year":"2018","unstructured":"Wang Y, Bi Y, Xia Z, Shi W, Li B, Li B, Chen L, et al. Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia. Biochem Biophys Res Commun. 2018;497:80\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"1095_CR14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbrc.2020.03.180","volume":"527","author":"Y Arao","year":"2020","unstructured":"Arao Y, Kawai H, Kamimura K, Kobayashi T, Nakano O, Hayatsu M, Ushiki T, et al. Effect of methionine\/choline-deficient diet and high-fat diet-induced steatohepatitis on mitochondrial homeostasis in mice. Biochem Biophys Res Commun. 2020;527:365\u201371.","journal-title":"Biochem Biophys Res Commun"},{"key":"1095_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cell.2011.11.030","volume":"148","author":"Z Wang","year":"2012","unstructured":"Wang Z, Jiang H, Chen S, Du F, Wang X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell. 2012;148:228\u201343.","journal-title":"Cell"},{"key":"1095_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.molcel.2016.02.022","volume":"61","author":"E Schrepfer","year":"2016","unstructured":"Schrepfer E, Scorrano L. Mitofusins, from mitochondria to metabolism. Mol Cell. 2016;61:683\u201394.","journal-title":"Mol Cell"},{"key":"1095_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2012.09.015","volume":"38","author":"TB Kang","year":"2013","unstructured":"Kang TB, Yang SH, Toth B, Kovalenko A, Wallach D. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity. 2013;38:27\u201340.","journal-title":"Immunity"},{"key":"1095_CR18","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1038\/s41467-020-16312-7","volume":"11","author":"B Yu","year":"2020","unstructured":"Yu B, Ma J, Li J, Wang D, Wang Z, Wang S. Mitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics. Nat Commun. 2020;11:2549.","journal-title":"Nat Commun"},{"key":"1095_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/gastroent13020016","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu S, Yang M. The role of interferon regulatory factors in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Gastroenterol Insights. 2022;13:148\u201361.","journal-title":"Gastroenterol Insights"},{"key":"1095_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/jir.2014.0096","volume":"35","author":"R Shimozono","year":"2015","unstructured":"Shimozono R, Nishimura K, Akiyama H, Funamoto S, Izawa A, Sai T, Kunita K, et al. Interferon-\u03b2 mediates signaling pathways uniquely regulated in hepatic stellate cells and attenuates the progression of hepatic fibrosis in a dietary mouse model. J Interferon Cytokine Res. 2015;35:464\u201373.","journal-title":"J Interferon Cytokine Res"},{"key":"1095_CR21","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/hep.26751","volume":"59","author":"X-A Wang","year":"2014","unstructured":"Wang X-A, Zhang R, She Z-G, Zhang X-F, Jiang D-S, Wang T, Gao L, et al. Interferon regulatory factor 3 constrains IKK\u03b2\/NF-\u03baB signaling to alleviate hepatic steatosis and insulin resistance. Hepatology. 2014;59:870\u201385.","journal-title":"Hepatology"},{"key":"1095_CR22","doi-asserted-by":"publisher","first-page":"11818","DOI":"10.1073\/pnas.1716173114","volume":"114","author":"DM Sabatini","year":"2017","unstructured":"Sabatini DM. Twenty-five years of mTOR: uncovering the link from nutrients to growth. Proc Natl Acad Sci. 2017;114:11818\u201325.","journal-title":"Proc Natl Acad Sci"},{"key":"1095_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41580-021-00411-4","volume":"23","author":"CL Green","year":"2022","unstructured":"Green CL, Lamming DW, Fontana L. Molecular mechanisms of dietary restriction promoting health and longevity. Nat Rev Mol Cell Biol. 2022;23:56\u201373.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1095_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.lfs.2018.03.017","volume":"200","author":"JM Hong","year":"2018","unstructured":"Hong JM, Lee SM. Heme oxygenase-1 protects liver against ischemia\/reperfusion injury via phosphoglycerate mutase family member 5-mediated mitochondrial quality control. Life Sci. 2018;200:94\u2013104.","journal-title":"Life Sci"},{"key":"1095_CR25","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1021\/acs.biochem.6b00306","volume":"55","author":"AM Lenhausen","year":"2016","unstructured":"Lenhausen AM, Wilkinson AS, Lewis EM, Dailey KM, Scott AJ, Khan S, Wilkinson JC. Apoptosis inducing factor binding protein PGAM5 triggers mitophagic cell death that is inhibited by the ubiquitin ligase activity of X-linked inhibitor of apoptosis. Biochemistry. 2016;55:3285\u2013302.","journal-title":"Biochemistry"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-023-01095-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-023-01095-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-023-01095-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T19:23:11Z","timestamp":1700421791000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-023-01095-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1095"],"URL":"https:\/\/doi.org\/10.1186\/s13578-023-01095-3","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"17 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the institution at which the studies were conducted and ethical approval was obtained from Animal Research Committee of the Peking University People\u2019s Hospital (2019PHC013). Human work was approved by the Ethics Committee of Peking University People\u2019s Hospital (2022PHB088-001) and obeyed the rules of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}